0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Biotechnology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-16R6211
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biotechnology Market Insights and Forecast to 2028
BUY CHAPTERS

Biotechnology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-16R6211
Report
September 2024
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biotechnology - Market Size

The global market for Biotechnology was estimated to be worth US$ 514060 million in 2023 and is forecast to a readjusted size of US$ 857040 million by 2030 with a CAGR of 7.4% during the forecast period 2024-2030

Biotechnology - Market

Biotechnology - Market

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies.
North American market for Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Biotechnology include Johnson & Johnson, Roche, Pfizer, Merck, Sanofi, AstraZeneca, Gilead, CELGENE CORPORATION and Biogen, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biotechnology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biotechnology by region & country, by Type, and by Application.
The Biotechnology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotechnology.
Market Segmentation

Scope of Biotechnology - Market Report

Report Metric Details
Report Name Biotechnology - Market
Forecasted market size in 2030 US$ 857040 million
CAGR 7.4%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Health
  • Food & Agriculture
  • Natural Resources & Environment
  • Industrial Processing
  • Bioinformatics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Roche, Pfizer, Merck, Sanofi, AstraZeneca, Gilead, CELGENE CORPORATION, Biogen, Amgen, Abbott, Novo Nordisk, Novartis, Lonza, BioNTech, Moderna, Regeneron, Vertex, Jazz Pharmaceuticals, Incyte, BioMarin, Genmab, Novavax
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Biotechnology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Biotechnology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Biotechnology in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Biotechnology - Market size in 2030?

Ans: The Biotechnology - Market size in 2030 will be US$ 857040 million.

Who are the main players in the Biotechnology - Market report?

Ans: The main players in the Biotechnology - Market are Johnson & Johnson, Roche, Pfizer, Merck, Sanofi, AstraZeneca, Gilead, CELGENE CORPORATION, Biogen, Amgen, Abbott, Novo Nordisk, Novartis, Lonza, BioNTech, Moderna, Regeneron, Vertex, Jazz Pharmaceuticals, Incyte, BioMarin, Genmab, Novavax

What are the Application segmentation covered in the Biotechnology - Market report?

Ans: The Applications covered in the Biotechnology - Market report are Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, Others

What are the Type segmentation covered in the Biotechnology - Market report?

Ans: The Types covered in the Biotechnology - Market report are DNA Sequencing, Nanobiotechnology, Tissue Engineering and Regeneration, Fermentation, Cell Based Assay, PCR Technology, Chromatography Market, Others

Recommended Reports

Gene & Cell Therapy

Drug Delivery & Diagnostics

Biopharma & Research Tools

1 Market Overview
1.1 Biotechnology Product Introduction
1.2 Global Biotechnology Market Size Forecast
1.3 Biotechnology Market Trends & Drivers
1.3.1 Biotechnology Industry Trends
1.3.2 Biotechnology Market Drivers & Opportunity
1.3.3 Biotechnology Market Challenges
1.3.4 Biotechnology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biotechnology Players Revenue Ranking (2023)
2.2 Global Biotechnology Revenue by Company (2019-2024)
2.3 Key Companies Biotechnology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biotechnology Product Offered
2.5 Key Companies Time to Begin Mass Production of Biotechnology
2.6 Biotechnology Market Competitive Analysis
2.6.1 Biotechnology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biotechnology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 DNA Sequencing
3.1.2 Nanobiotechnology
3.1.3 Tissue Engineering and Regeneration
3.1.4 Fermentation
3.1.5 Cell Based Assay
3.1.6 PCR Technology
3.1.7 Chromatography Market
3.1.8 Others
3.2 Global Biotechnology Sales Value by Type
3.2.1 Global Biotechnology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biotechnology Sales Value, by Type (2019-2030)
3.2.3 Global Biotechnology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Health
4.1.2 Food & Agriculture
4.1.3 Natural Resources & Environment
4.1.4 Industrial Processing
4.1.5 Bioinformatics
4.1.6 Others
4.2 Global Biotechnology Sales Value by Application
4.2.1 Global Biotechnology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biotechnology Sales Value, by Application (2019-2030)
4.2.3 Global Biotechnology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biotechnology Sales Value by Region
5.1.1 Global Biotechnology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biotechnology Sales Value by Region (2019-2024)
5.1.3 Global Biotechnology Sales Value by Region (2025-2030)
5.1.4 Global Biotechnology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biotechnology Sales Value, 2019-2030
5.2.2 North America Biotechnology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biotechnology Sales Value, 2019-2030
5.3.2 Europe Biotechnology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biotechnology Sales Value, 2019-2030
5.4.2 Asia Pacific Biotechnology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biotechnology Sales Value, 2019-2030
5.5.2 South America Biotechnology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biotechnology Sales Value, 2019-2030
5.6.2 Middle East & Africa Biotechnology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biotechnology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biotechnology Sales Value
6.3 United States
6.3.1 United States Biotechnology Sales Value, 2019-2030
6.3.2 United States Biotechnology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biotechnology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biotechnology Sales Value, 2019-2030
6.4.2 Europe Biotechnology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biotechnology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biotechnology Sales Value, 2019-2030
6.5.2 China Biotechnology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biotechnology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biotechnology Sales Value, 2019-2030
6.6.2 Japan Biotechnology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biotechnology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biotechnology Sales Value, 2019-2030
6.7.2 South Korea Biotechnology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biotechnology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biotechnology Sales Value, 2019-2030
6.8.2 Southeast Asia Biotechnology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biotechnology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biotechnology Sales Value, 2019-2030
6.9.2 India Biotechnology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biotechnology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Profile
7.1.2 Johnson & Johnson Main Business
7.1.3 Johnson & Johnson Biotechnology Products, Services and Solutions
7.1.4 Johnson & Johnson Biotechnology Revenue (US$ Million) & (2019-2024)
7.1.5 Johnson & Johnson Recent Developments
7.2 Roche
7.2.1 Roche Profile
7.2.2 Roche Main Business
7.2.3 Roche Biotechnology Products, Services and Solutions
7.2.4 Roche Biotechnology Revenue (US$ Million) & (2019-2024)
7.2.5 Roche Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Biotechnology Products, Services and Solutions
7.3.4 Pfizer Biotechnology Revenue (US$ Million) & (2019-2024)
7.3.5 Merck Recent Developments
7.4 Merck
7.4.1 Merck Profile
7.4.2 Merck Main Business
7.4.3 Merck Biotechnology Products, Services and Solutions
7.4.4 Merck Biotechnology Revenue (US$ Million) & (2019-2024)
7.4.5 Merck Recent Developments
7.5 Sanofi
7.5.1 Sanofi Profile
7.5.2 Sanofi Main Business
7.5.3 Sanofi Biotechnology Products, Services and Solutions
7.5.4 Sanofi Biotechnology Revenue (US$ Million) & (2019-2024)
7.5.5 Sanofi Recent Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Profile
7.6.2 AstraZeneca Main Business
7.6.3 AstraZeneca Biotechnology Products, Services and Solutions
7.6.4 AstraZeneca Biotechnology Revenue (US$ Million) & (2019-2024)
7.6.5 AstraZeneca Recent Developments
7.7 Gilead
7.7.1 Gilead Profile
7.7.2 Gilead Main Business
7.7.3 Gilead Biotechnology Products, Services and Solutions
7.7.4 Gilead Biotechnology Revenue (US$ Million) & (2019-2024)
7.7.5 Gilead Recent Developments
7.8 CELGENE CORPORATION
7.8.1 CELGENE CORPORATION Profile
7.8.2 CELGENE CORPORATION Main Business
7.8.3 CELGENE CORPORATION Biotechnology Products, Services and Solutions
7.8.4 CELGENE CORPORATION Biotechnology Revenue (US$ Million) & (2019-2024)
7.8.5 CELGENE CORPORATION Recent Developments
7.9 Biogen
7.9.1 Biogen Profile
7.9.2 Biogen Main Business
7.9.3 Biogen Biotechnology Products, Services and Solutions
7.9.4 Biogen Biotechnology Revenue (US$ Million) & (2019-2024)
7.9.5 Biogen Recent Developments
7.10 Amgen
7.10.1 Amgen Profile
7.10.2 Amgen Main Business
7.10.3 Amgen Biotechnology Products, Services and Solutions
7.10.4 Amgen Biotechnology Revenue (US$ Million) & (2019-2024)
7.10.5 Amgen Recent Developments
7.11 Abbott
7.11.1 Abbott Profile
7.11.2 Abbott Main Business
7.11.3 Abbott Biotechnology Products, Services and Solutions
7.11.4 Abbott Biotechnology Revenue (US$ Million) & (2019-2024)
7.11.5 Abbott Recent Developments
7.12 Novo Nordisk
7.12.1 Novo Nordisk Profile
7.12.2 Novo Nordisk Main Business
7.12.3 Novo Nordisk Biotechnology Products, Services and Solutions
7.12.4 Novo Nordisk Biotechnology Revenue (US$ Million) & (2019-2024)
7.12.5 Novo Nordisk Recent Developments
7.13 Novartis
7.13.1 Novartis Profile
7.13.2 Novartis Main Business
7.13.3 Novartis Biotechnology Products, Services and Solutions
7.13.4 Novartis Biotechnology Revenue (US$ Million) & (2019-2024)
7.13.5 Novartis Recent Developments
7.14 Lonza
7.14.1 Lonza Profile
7.14.2 Lonza Main Business
7.14.3 Lonza Biotechnology Products, Services and Solutions
7.14.4 Lonza Biotechnology Revenue (US$ Million) & (2019-2024)
7.14.5 Lonza Recent Developments
7.15 BioNTech
7.15.1 BioNTech Profile
7.15.2 BioNTech Main Business
7.15.3 BioNTech Biotechnology Products, Services and Solutions
7.15.4 BioNTech Biotechnology Revenue (US$ Million) & (2019-2024)
7.15.5 BioNTech Recent Developments
7.16 Moderna
7.16.1 Moderna Profile
7.16.2 Moderna Main Business
7.16.3 Moderna Biotechnology Products, Services and Solutions
7.16.4 Moderna Biotechnology Revenue (US$ Million) & (2019-2024)
7.16.5 Moderna Recent Developments
7.17 Regeneron
7.17.1 Regeneron Profile
7.17.2 Regeneron Main Business
7.17.3 Regeneron Biotechnology Products, Services and Solutions
7.17.4 Regeneron Biotechnology Revenue (US$ Million) & (2019-2024)
7.17.5 Regeneron Recent Developments
7.18 Vertex
7.18.1 Vertex Profile
7.18.2 Vertex Main Business
7.18.3 Vertex Biotechnology Products, Services and Solutions
7.18.4 Vertex Biotechnology Revenue (US$ Million) & (2019-2024)
7.18.5 Vertex Recent Developments
7.19 Jazz Pharmaceuticals
7.19.1 Jazz Pharmaceuticals Profile
7.19.2 Jazz Pharmaceuticals Main Business
7.19.3 Jazz Pharmaceuticals Biotechnology Products, Services and Solutions
7.19.4 Jazz Pharmaceuticals Biotechnology Revenue (US$ Million) & (2019-2024)
7.19.5 Jazz Pharmaceuticals Recent Developments
7.20 Incyte
7.20.1 Incyte Profile
7.20.2 Incyte Main Business
7.20.3 Incyte Biotechnology Products, Services and Solutions
7.20.4 Incyte Biotechnology Revenue (US$ Million) & (2019-2024)
7.20.5 Incyte Recent Developments
7.21 BioMarin
7.21.1 BioMarin Profile
7.21.2 BioMarin Main Business
7.21.3 BioMarin Biotechnology Products, Services and Solutions
7.21.4 BioMarin Biotechnology Revenue (US$ Million) & (2019-2024)
7.21.5 BioMarin Recent Developments
7.22 Genmab
7.22.1 Genmab Profile
7.22.2 Genmab Main Business
7.22.3 Genmab Biotechnology Products, Services and Solutions
7.22.4 Genmab Biotechnology Revenue (US$ Million) & (2019-2024)
7.22.5 Genmab Recent Developments
7.23 Novavax
7.23.1 Novavax Profile
7.23.2 Novavax Main Business
7.23.3 Novavax Biotechnology Products, Services and Solutions
7.23.4 Novavax Biotechnology Revenue (US$ Million) & (2019-2024)
7.23.5 Novavax Recent Developments
8 Industry Chain Analysis
8.1 Biotechnology Industrial Chain
8.2 Biotechnology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biotechnology Sales Model
8.5.2 Sales Channel
8.5.3 Biotechnology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Biotechnology Market Trends
    Table 2. Biotechnology Market Drivers & Opportunity
    Table 3. Biotechnology Market Challenges
    Table 4. Biotechnology Market Restraints
    Table 5. Global Biotechnology Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Biotechnology Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Biotechnology Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Biotechnology Product Type
    Table 9. Key Companies Time to Begin Mass Production of Biotechnology
    Table 10. Global Biotechnology Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnology as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Biotechnology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Biotechnology Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Biotechnology Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Biotechnology Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Biotechnology Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Biotechnology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Biotechnology Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Biotechnology Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Biotechnology Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Biotechnology Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Biotechnology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Biotechnology Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Biotechnology Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Biotechnology Sales Value by Region (2019-2024) & (%)
    Table 27. Global Biotechnology Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Biotechnology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Biotechnology Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Biotechnology Sales Value, (2025-2030) & (US$ Million)
    Table 31. Johnson & Johnson Basic Information List
    Table 32. Johnson & Johnson Description and Business Overview
    Table 33. Johnson & Johnson Biotechnology Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Biotechnology Business of Johnson & Johnson (2019-2024)
    Table 35. Johnson & Johnson Recent Developments
    Table 36. Roche Basic Information List
    Table 37. Roche Description and Business Overview
    Table 38. Roche Biotechnology Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Biotechnology Business of Roche (2019-2024)
    Table 40. Roche Recent Developments
    Table 41. Pfizer Basic Information List
    Table 42. Pfizer Description and Business Overview
    Table 43. Pfizer Biotechnology Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Biotechnology Business of Pfizer (2019-2024)
    Table 45. Pfizer Recent Developments
    Table 46. Merck Basic Information List
    Table 47. Merck Description and Business Overview
    Table 48. Merck Biotechnology Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Biotechnology Business of Merck (2019-2024)
    Table 50. Merck Recent Developments
    Table 51. Sanofi Basic Information List
    Table 52. Sanofi Description and Business Overview
    Table 53. Sanofi Biotechnology Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Biotechnology Business of Sanofi (2019-2024)
    Table 55. Sanofi Recent Developments
    Table 56. AstraZeneca Basic Information List
    Table 57. AstraZeneca Description and Business Overview
    Table 58. AstraZeneca Biotechnology Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Biotechnology Business of AstraZeneca (2019-2024)
    Table 60. AstraZeneca Recent Developments
    Table 61. Gilead Basic Information List
    Table 62. Gilead Description and Business Overview
    Table 63. Gilead Biotechnology Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Biotechnology Business of Gilead (2019-2024)
    Table 65. Gilead Recent Developments
    Table 66. CELGENE CORPORATION Basic Information List
    Table 67. CELGENE CORPORATION Description and Business Overview
    Table 68. CELGENE CORPORATION Biotechnology Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Biotechnology Business of CELGENE CORPORATION (2019-2024)
    Table 70. CELGENE CORPORATION Recent Developments
    Table 71. Biogen Basic Information List
    Table 72. Biogen Description and Business Overview
    Table 73. Biogen Biotechnology Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Biotechnology Business of Biogen (2019-2024)
    Table 75. Biogen Recent Developments
    Table 76. Amgen Basic Information List
    Table 77. Amgen Description and Business Overview
    Table 78. Amgen Biotechnology Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Biotechnology Business of Amgen (2019-2024)
    Table 80. Amgen Recent Developments
    Table 81. Abbott Basic Information List
    Table 82. Abbott Description and Business Overview
    Table 83. Abbott Biotechnology Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Biotechnology Business of Abbott (2019-2024)
    Table 85. Abbott Recent Developments
    Table 86. Novo Nordisk Basic Information List
    Table 87. Novo Nordisk Description and Business Overview
    Table 88. Novo Nordisk Biotechnology Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Biotechnology Business of Novo Nordisk (2019-2024)
    Table 90. Novo Nordisk Recent Developments
    Table 91. Novartis Basic Information List
    Table 92. Novartis Description and Business Overview
    Table 93. Novartis Biotechnology Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Biotechnology Business of Novartis (2019-2024)
    Table 95. Novartis Recent Developments
    Table 96. Lonza Basic Information List
    Table 97. Lonza Description and Business Overview
    Table 98. Lonza Biotechnology Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Biotechnology Business of Lonza (2019-2024)
    Table 100. Lonza Recent Developments
    Table 101. BioNTech Basic Information List
    Table 102. BioNTech Description and Business Overview
    Table 103. BioNTech Biotechnology Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Biotechnology Business of BioNTech (2019-2024)
    Table 105. BioNTech Recent Developments
    Table 106. Moderna Basic Information List
    Table 107. Moderna Description and Business Overview
    Table 108. Moderna Biotechnology Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Biotechnology Business of Moderna (2019-2024)
    Table 110. Moderna Recent Developments
    Table 111. Regeneron Basic Information List
    Table 112. Regeneron Description and Business Overview
    Table 113. Regeneron Biotechnology Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Biotechnology Business of Regeneron (2019-2024)
    Table 115. Regeneron Recent Developments
    Table 116. Vertex Basic Information List
    Table 117. Vertex Description and Business Overview
    Table 118. Vertex Biotechnology Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Biotechnology Business of Vertex (2019-2024)
    Table 120. Vertex Recent Developments
    Table 121. Jazz Pharmaceuticals Basic Information List
    Table 122. Jazz Pharmaceuticals Description and Business Overview
    Table 123. Jazz Pharmaceuticals Biotechnology Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Biotechnology Business of Jazz Pharmaceuticals (2019-2024)
    Table 125. Jazz Pharmaceuticals Recent Developments
    Table 126. Incyte Basic Information List
    Table 127. Incyte Description and Business Overview
    Table 128. Incyte Biotechnology Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Biotechnology Business of Incyte (2019-2024)
    Table 130. Incyte Recent Developments
    Table 131. BioMarin Basic Information List
    Table 132. BioMarin Description and Business Overview
    Table 133. BioMarin Biotechnology Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Biotechnology Business of BioMarin (2019-2024)
    Table 135. BioMarin Recent Developments
    Table 136. Genmab Basic Information List
    Table 137. Genmab Description and Business Overview
    Table 138. Genmab Biotechnology Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Biotechnology Business of Genmab (2019-2024)
    Table 140. Genmab Recent Developments
    Table 141. Novavax Basic Information List
    Table 142. Novavax Description and Business Overview
    Table 143. Novavax Biotechnology Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Biotechnology Business of Novavax (2019-2024)
    Table 145. Novavax Recent Developments
    Table 146. Key Raw Materials Lists
    Table 147. Raw Materials Key Suppliers Lists
    Table 148. Biotechnology Downstream Customers
    Table 149. Biotechnology Distributors List
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
    Table 153. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Biotechnology Product Picture
    Figure 2. Global Biotechnology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 4. Biotechnology Report Years Considered
    Figure 5. Global Biotechnology Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biotechnology Revenue in 2023
    Figure 7. Biotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. DNA Sequencing Picture
    Figure 9. Nanobiotechnology Picture
    Figure 10. Tissue Engineering and Regeneration Picture
    Figure 11. Fermentation Picture
    Figure 12. Cell Based Assay Picture
    Figure 13. PCR Technology Picture
    Figure 14. Chromatography Market Picture
    Figure 15. Others Picture
    Figure 16. Global Biotechnology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Biotechnology Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Product Picture of Health
    Figure 19. Product Picture of Food & Agriculture
    Figure 20. Product Picture of Natural Resources & Environment
    Figure 21. Product Picture of Industrial Processing
    Figure 22. Product Picture of Bioinformatics
    Figure 23. Product Picture of Others
    Figure 24. Global Biotechnology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Biotechnology Sales Value Market Share by Application, 2023 & 2030
    Figure 26. North America Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Biotechnology Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Biotechnology Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Biotechnology Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Biotechnology Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Biotechnology Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Biotechnology Sales Value (%), (2019-2030)
    Figure 37. United States Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 58. Biotechnology Industrial Chain
    Figure 59. Biotechnology Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart